MedPath

HOSPITAL UNIVERSITARIO INFANTA CRISTINA

🇪🇸Spain
Ownership
-
Established
2008-01-01
Employees
-
Market Cap
-
Website
http://www.madrid.org/cs/Satellite?language=es&pagename=HospitalInfantaCristina/Page/HSUR_home

Clinical Trials

6

Active:1
Completed:4

Trial Phases

2 Phases

Phase 4:2
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 4
2 (66.7%)
Not Applicable
1 (33.3%)

Evaluate the Outcomes of Ferric Carboxymaltose in Patients With Perioperative Anemia

Completed
Conditions
Anemia
Anemia (Iron-Loading)
Perioperative Bleeding
Infection Prevention
Readmission, Hospital
Surgical Complication
Length of Hospital Stay
Iron Deficiency Anemia Treatment
Prehabilitation
Interventions
Drug: Ferric Carboxymaltose (FCM)
First Posted Date
2025-04-29
Last Posted Date
2025-05-02
Lead Sponsor
Hospital Universitario Infanta Cristina
Target Recruit Count
152
Registration Number
NCT06948864
Locations
🇪🇸

Hospital Universitario Infanta Cristina, Parla, Madrid, Spain

Resection of the Inferior Vena Cava Due to Tumor Involvement

Completed
Conditions
Surgery--Complications
Vein Disease
Neoplasms
Vascular Diseases
First Posted Date
2019-11-06
Last Posted Date
2019-11-08
Lead Sponsor
Hospital Universitario Infanta Cristina
Target Recruit Count
13
Registration Number
NCT04154761
Locations
🇪🇸

Diego López-Guerra, Badajoz, Spain

The Titan Versus Everolimus Intracoronary Stent (Xience V) in Diabetic Patients

Phase 4
Conditions
Diabetes Mellitus
Percutaneous Coronary Intervention
First Posted Date
2012-01-16
Last Posted Date
2012-01-16
Lead Sponsor
Hospital Universitario Infanta Cristina
Registration Number
NCT01510509
Locations
🇫🇮

Heart Center, Satakunta Hospital, Pori, Finland, Satakunta, Pori, Finland

🇪🇸

Hospital de Torrevieja, Torrevieja, Alicante, Spain

🇪🇸

Hospital Puerto Real de Cádiz, Puerto Real, Cadiz, Spain

and more 5 locations

Usefulness of Lidocaine as Topical Pharyngeal Anaesthesia in Esophagogastroduodenoscopy Under Sedation With Propofol

Phase 4
Completed
Conditions
Esophagogastroduodenoscopy
Interventions
Drug: Placebo
First Posted Date
2011-12-12
Last Posted Date
2013-03-08
Lead Sponsor
Hospital Universitario Infanta Cristina
Target Recruit Count
120
Registration Number
NCT01489891
Locations
🇪🇸

Hospital Universitario Infanta Cristina, Parla, Madrid, Spain

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.